Purple Biotech Operating Expenses Growth & History (PPBT)
Purple Biotech's operating expenses was $27.5M for fiscal 2025.
View full Purple Biotech company overviewPurple Biotech annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $27.5M | $16.5M | +149.50% |
| 2024 | 2024-12-31 | $11.0M | −$11.3M | −50.59% |
| 2023 | 2023-12-31 | $22.3M | −$332,000 | −1.47% |
| 2022 | 2022-12-31 | $22.6M | $4.7M | +26.03% |
| 2021 | 2021-12-31 | $17.9M | $4.7M | +35.46% |
| 2020 | 2020-12-31 | $13.2M | $6.6M | +98.46% |
| 2019 | 2019-12-31 | $6.7M | −$2.2M | −24.42% |
| 2018 | 2018-12-31 | $8.8M | −$3.2M | −26.85% |
| 2017 | 2017-12-31 | $12.1M | $4.9M | +67.98% |
| 2016 | 2016-12-31 | $7.2M | — | — |
Purple Biotech quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.3M | $63,000 | +5.10% |
| Q1 2026 | 2026-03-31 | $2.3M | — | — |
| Q4 2025 | 2025-12-31 | $3.0M | — | — |
| Q3 2025 | 2025-09-30 | $1.4M | — | — |
| Q2 2025 | 2025-06-30 | $1.2M | — | — |
Purple Biotech operating expenses trends
Over the last five fiscal years, Purple Biotech's operating expenses increased from $13.2M to $27.5M, a change of $14.2M. The latest reported quarter, Q2 2026, shows $1.3M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Purple Biotech source filings ↗